Diagnosis: Dapsone hypersensitivity syndrome
A 32-year-old male presents with fever, rash, and elevated liver enzymes three weeks after starting dapsone for dermatitis herpetiformis. He exhibits systemic symptoms and a widespread rash, raising concern for a severe drug reaction. This case highlights the importance of recognizing early signs of hypersensitivity to dapsone and the need for prompt intervention.
A 32-year-old male with a history of dermatitis herpetiformis presents to the clinic with fever, a generalized rash, and elevated liver enzymes three weeks after initiating dapsone therapy. On examination, he is febrile and has a diffuse, erythematous rash with mucosal involvement. Liver function tests reveal transaminitis.Fever: Documented temperature of 39°C.Rash: Widespread erythematous macules and papules, some with vesicular lesions.Liver involvement: Elevated AST and ALT, indicating hepatic injury.Mucosal lesions: Oral ulcers noted on examination.Constitutional symptoms: Patient reports malaise and fatigue.
The patient first noticed symptoms two weeks after starting dapsone, which was prescribed for his dermatitis herpetiformis. He has no known drug allergies and has previously tolerated similar medications without issue. There is no significant past medical history of liver disease or autoimmune conditions. He denies recent infections or travel history. He works as a teacher and has no known exposure to toxins or new medications.Onset: Symptoms began two weeks post-initiation of dapsone.Triggers: No recent changes in medications or significant environmental exposures.Prior treatments: Previously treated with gluten-free diet and topical steroids.Family history: No history of drug reactions or autoimmune diseases.Social history: Non-smoker, moderate alcohol consumption, no recreational drug use.
Acute / First-Line ManagementImmediate discontinuation of dapsone.Supportive care including hydration and antipyretics for fever.Consider systemic corticosteroids (e.g., prednisone 0.5-1 mg/kg/day) to manage severe reactions.Workup and Diagnostic ConfirmationComplete blood count (CBC) to evaluate for eosinophilia.Liver function tests (LFTs) to assess the extent of hepatic involvement.Skin biopsy may be considered to rule out other conditions, showing a perivascular infiltrate.Patch testing can be performed in the future for confirmation of dapsone sensitivity.Long-Term ManagementReferral to a dermatologist for follow-up and management of dermatitis herpetiformis.Consider alternative medications for dermatitis herpetiformis, such as sulfapyridine or other immunosuppressants.Patient education on recognizing signs of drug reactions in the future.
Stevens-Johnson syndrome: Characterized by mucosal involvement and severe skin detachment, often triggered by medications, but typically presents more acutely.Toxic epidermal necrolysis: More severe than SJS, presenting with extensive skin detachment and systemic symptoms, often requiring hospitalization.Drug-induced liver injury: Can present with fever and rash; however, it may not have the mucosal involvement seen in hypersensitivity reactions.Viral exanthems: Commonly present with fever and rash but usually associated with a recent viral illness and are self-limiting.Autoimmune drug reaction: Conditions such as drug-induced lupus can present similarly but typically have a more prolonged course and systemic features.Fixed drug eruption: Localized lesions that recur at the same site upon re-exposure to the offending agent, unlike the generalized rash seen here.Graft-versus-host disease: May present with similar symptoms in post-transplant patients but is less common in the general population.Other drug reactions: Such as erythema multiforme, which can cause target lesions but typically does not cause systemic symptoms like fever and hepatitis.
High-Yield PearlsDapsone hypersensitivity: This syndrome can present with fever, rash, and hepatic dysfunction, often occurring 2-8 weeks after drug initiation.Clinical vigilance: Early recognition of symptoms is critical to prevent severe outcomes, including potential liver failure.Drug discontinuation: Immediate cessation of the offending agent is the first step in management.Corticosteroids: Systemic corticosteroids may be necessary in severe cases to mitigate the immune response.Patient education: Educating patients about recognizing symptoms of drug hypersensitivity is essential for future safety.Recognizing dapsone hypersensitivity syndrome early can significantly alter the clinical course and improve patient outcomes.
Tags: dapsone, hypersensitivity, drug reaction